Experimental therapy for neurofibromatosis I shows promise: cancer drug shrinks some plexiform neuromas.
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D000068877:Imatinib Mesylate; D018318:Neurofibroma, Plexiform / Q000188:drug therapy* / Q000473:pathology; D009456:Neurofibromatosis 1 / Q000188:drug therapy* / Q000473:pathology; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D035703:Therapies, Investigational; D047368:Tumor Burden / Q000187:drug effects
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate